How Tirzepatide Works
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist. Understanding how it works helps you make informed decisions about your treatment.
The Science Behind Tirzepatide
The Injection Process
Tirzepatide is administered as a once-weekly subcutaneous injection. Here's what to expect:
Dosing Schedule
Tirzepatide follows a gradual dose-escalation schedule to help minimize gastrointestinal side effects.
Weeks 1-4
Starting dose to minimize side effects
Weeks 5-8
First therapeutic dose increase
Weeks 9-12
Intermediate dose if needed
Weeks 13-16
Higher dose for additional effect
Weeks 17-20
Continued escalation if tolerated
Weeks 21+
Maximum dose
Your healthcare provider will determine the appropriate dosing schedule based on your individual response and tolerability.
Want to Learn About the Benefits?
Discover the clinical results and health improvements associated with Tirzepatide treatment.
View Benefits